H1B Salary Data

Home › Employers › North Shore Medical Center

North Shore Medical Center: H-1B salaries and sponsorship

North Shore Medical Center filed 10 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 10. Median offered salary: $78,540.

Applications (LCAs)10
Certified10
Employer addressSomerville, MA
H-1B dependent employerNo
Median offered salary$78,540
Middle half of salaries$76,900–$78,540
10th–90th percentile$74,000–$78,540

Does North Shore Medical Center sponsor H-1B visas?

North Shore Medical Center filed 10 labor condition applications in fiscal years 2023–2026, the latest submitted on Mar 31, 2023. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Resident10$78,540

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY202310$78,540

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Resident$78,540Boston, MAMar 31, 2023Jun 19, 2023Certified
Resident$78,540Boston, MAMar 31, 2023Jun 19, 2023Certified
Resident$78,540Boston, MAMar 31, 2023Jun 19, 2023Certified
Resident$78,540Boston, MAMar 30, 2023Jun 19, 2023Certified
Resident$78,540Boston, MAMar 30, 2023Jun 19, 2023Certified
Resident$78,540Boston, MAMar 28, 2023Jun 19, 2023Certified
Resident$76,900Boston, MAFeb 28, 2023Jun 26, 2023Certified
Resident$74,000–$92,000Boston, MAFeb 2, 2023Jun 26, 2023Certified
Resident$76,900Boston, MAFeb 2, 2023Jun 26, 2023Certified, then withdrawn
Resident$74,000–$92,000Boston, MAJan 30, 2023Jun 26, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).